Kaposi sarcoma

Description

Kaposi's sarcoma: A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).

Data source
FinnGen phenocode C3_KAPOSI_SARCOMA
Hospital Discharge registry ICD-10: C46
Cause of Death registry ICD-10: C46
Level in the ICD-hierarchy 3
First defined in version DF3
Ontology
DOID 8632
GWAS catalog 0000558
MESH D012514
SNOMED CT 109385007

Key figures

Sex All Female Male
Number of individuals 14 N/A 9
Unadjusted prevalence (%) 0.01 N/A 0.02
Mean age at first event (years) 62.98 N/A 60.85
Median number of events / individual 1 N/A 2

Clinical metrics

Sex All Female Male
Recurrence within 6 months (%) 35.71 N/A 44.44
Case fatality at 5-years (%) 21.43 N/A 11.11

Associations